Latest Ratings for FWONK Date Firm Action From To Feb 2022 JP Morgan Maintains Overweight Jan 2022 Morgan Stanley Maintains Equal-Weight Jul 2021 Morgan Stanley Maintains Equal-Weight View More Analyst Ratings for FWONK View the Latest Analyst Ratings read more
Latest Ratings for COTY Date Firm Action From To Jan 2022 Raymond James Maintains Outperform Jan 2022 DA Davidson Upgrades Neutral Buy Jan 2022 Morgan Stanley Maintains Equal-Weight View More Analyst Ratings for COTY View the Latest Analyst Ratings read more
Latest Ratings for SGHT Date Firm Action From To Feb 2022 William Blair Initiates Coverage On Outperform Jan 2022 Morgan Stanley Upgrades Equal-Weight Overweight Aug 2021 B of A Securities Initiates Coverage On Buy View More Analyst Ratings for SGHT View the Latest Analyst Ratings read more
Walmart Inc. (NYSE: WMT) shares are trading lower Thursday after the company posted mixed second-quarter results. read more
FDA approved Ionis’ Dawnzera for hereditary angioedema, showing up to 87% attack reduction and strong results in switch patients. read more
HC Wainwright backs Achieve Life Sciences with a Buy rating as cytisinicline nears potential 2026 FDA approval, targeting a large smoking cessation market. Latest Ratings for ACHV Date Firm Action From To Oct 2021 Alliance Global Partners Initiates Coverage On Buy Jun 2021 Oppenheimer Initiates Coverage On Outperform Sep 2020 Lake Street Initiates Coverage On…
Goldman Sachs traders predict a reversal for momentum stocks, putting pressure on ETFs linked to factors ahead of Nvidia’s earnings next week. read more
Latest Ratings for CHTR Date Firm Action From To Mar 2022 Truist Securities Downgrades Buy Hold Jan 2022 Deutsche Bank Maintains Hold Jan 2022 Barclays Maintains Equal-Weight View More Analyst Ratings for CHTR View the Latest Analyst Ratings read more